Skip to content

A Single-Center, Randomized Controlled Study on the Construction and Practice of a Triple Protection System for Wound Management After Sacral Tumor Surgery

A Single-Center, Randomized Controlled Study on the Construction and Practice of a Triple Protection System for Wound Management After Sacral Tumor Surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500110654
Enrollment
Unknown
Registered
2025-10-17
Start date
2025-11-01
Completion date
Unknown
Last updated
2025-10-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with fecal incontinence after sacral tumor surgery

Interventions

Control group:"Trinity" Wound Protection System
Intervention Group:"Trinity" Wound Protection System

Sponsors

Shanghai General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Patients after sacral tumor surgery who have varying degrees of fecal incontinence, including constipation, diarrhea, or normal stool consistency but frequent bowel movements; 2. Age between 18 and 75 years, capable of cooperating with observation and treatment, and possessing good communication skills and compliance; 3. Intact skin around the wound, without ulceration, infection, or other issues; 4. Patients are in good physiological and psychological condition during the postoperative recovery period and can independently complete the relevant questionnaires; 5. The participants and their families have been informed and agree to participate in this study, and have signed the relevant informed consent form.

Exclusion criteria

Exclusion criteria: 1.Patients with mental or consciousness impairments that preclude reliable evaluation; 2.Patients presenting with severe intestinal dysfunction (e.g., intestinal obstruction, inflammatory bowel disease); 3.Patients complicated by severe cardiopulmonary insufficiency, psychiatric disorders, or other conditions that may confound study outcomes; 4.Unwillingness to participate in the study or inability to comply with the study protocol; 5.Current enrollment in any other clinical trial.

Design outcomes

Primary

MeasureTime frame
Patient Wound Infection Rate;

Secondary

MeasureTime frame
Patient Wound Infection Rate;

Countries

China

Contacts

Public ContactZhang Xiaodan

Shanghai General Hospital

wzm1860@163.com+86 15221899889

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026